Argentina vs Bolivia, Plurinational State of: Treatment success rate for patients treated for MDR-TB
Argentina
45.0%
in 2022
Bolivia, Plurinational State of
42.0%
in 2022
Argentina rank
147th
Bolivia, Plurinational State of rank
149th
Treatment success rate for patients treated for MDR-TB over time
- Argentina
- Bolivia, Plurinational State of
How they compare
Argentina currently reports 45.0% against 42.0% in Bolivia, Plurinational State of, a difference of 3.0%.
That makes Argentina's figure about 1.1 times Bolivia, Plurinational State of's.
The two have swapped places 1 time across 12 shared years of data; in 2011 it was Bolivia, Plurinational State of ahead.
Argentina ranks 147th and Bolivia, Plurinational State of ranks 149th of 163 countries.
Bolivia, Plurinational State of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Bolivia, Plurinational State of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.3% | 63.2% | 34.9% | Bolivia, Plurinational State of |
| 2020s | 40.3% | 52.0% | 11.7% | Bolivia, Plurinational State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Argentina or Bolivia, Plurinational State of?
- Argentina, at 45.0% against 42.0% in Bolivia, Plurinational State of as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Argentina and Bolivia, Plurinational State of?
- 3.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Bolivia, Plurinational State of?
- 12 years are reported by both, from 2011 to 2022.
- How do Argentina and Bolivia, Plurinational State of rank globally for treatment success rate for patients treated for mdr-tb?
- Argentina ranks 147th and Bolivia, Plurinational State of ranks 149th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.